Clinical Trial: Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289763) titled 'Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy' on Nov. 20.

Brief Summary: To investigate the safety, efficacy, pharmacokinetics, and pharmacodynamics of SHR-2173 injection in patients with primary membranous nephropathy

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Primary Membranous Nephropathy

Intervention: DRUG: SHR-2173 injection

SHR-2173 injection, with a total of 8 administrations

DRUG: SHR-2173 injection

SHR-2173 injection, with a total of 16 ...